Variable | Group A Minoxidil 2% (n = 20) | Group B Ketoconazole 2% (n = 20) | MW | P | ||
Age (year) | ||||||
Mean ± SD | 29.05 ± 8.05 | 29.9 ± 10.09 | 0.08 | 0.94 | ||
Range | 28 (19–52) | 27 (19–50) | NS | |||
Variable | No. | % | No. | % | χ2 | P |
Family history | ||||||
-ve | 7 | 35 | 5 | 25 | 0.48 | 0.49 |
+ve | 13 | 65 | 15 | 75 | NS | |
Variable | MW | P | ||||
Disease duration (year) | ||||||
Mean ± SD | 2.75 ± 1.01 | 2.45 ± 1.15 | 0.89 | 0.37 | ||
Median (range) | 3 (1–5) | 2.5 (1–5) | NS | |||
Variable | No. | % | No. | % | χ2 | P |
Previous treatments | ||||||
No | 19 | 95 | 17 | 85 | ||
Platelet-rich plasma | 1 | 5 | 1 | 5 | 2.11 | 0.35 |
Minoxidil 5% | 0 | 0 | 2 | 10 | NS |